Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DNTH

Dianthus Therapeutics, Inc. /DE/

CIK 0001690585 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$100.03
↑ 1.96 (2.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options

Key stats

Market Cap
$5.47B
P/E Ratio
-31.49
EPS
-4.20
Dividend Yield
Not covered
52W Position
97%
Beta
1.03

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
4.55
P/S
766.08
EV/Revenue
678.14
ROE
-14.5%
Valuation data covers 8,499/9,463 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 97%
$18.08$102.33

Latest Financials

2025-12-31 FY
Revenue
$2.04M
Net Income
-$162.34M
Total Assets
$530.92M
Free Cash Flow
-$129.27M

Recent news